Search company, investor...

Mimetix Pharmaceuticals


Biz Plan Competition | Alive

About Mimetix Pharmaceuticals

Free Radical Scavengers developed from Duke's BME Department for treating and preventing diseases from occurring.

Headquarters Location

49 Stevenson Street Suite 550

San Francisco, California, 94105,

United States

Missing: Mimetix Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Mimetix Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Mimetix Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is Mimetix Pharmaceuticals's headquarters?

    Mimetix Pharmaceuticals's headquarters is located at 49 Stevenson Street, San Francisco.

  • What is Mimetix Pharmaceuticals's latest funding round?

    Mimetix Pharmaceuticals's latest funding round is Biz Plan Competition.

  • Who are the investors of Mimetix Pharmaceuticals?

    Investors of Mimetix Pharmaceuticals include Duke Start-up Challenge.

  • Who are Mimetix Pharmaceuticals's competitors?

    Competitors of Mimetix Pharmaceuticals include Zosano Pharma, United Biomedical, Intarcia Therapeutics, Icagen, CoLucid Pharmaceuticals and 13 more.

Compare Mimetix Pharmaceuticals to Competitors

Leuko Bioscience

Leuko Bioscience is aimed at treating diseases of the immune system


MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part of its unique product development philosophy, MacuSight also concentrates on the optimal delivery of these compounds into the eye. By combining its compounds with innovative delivery approaches, the company strives to optimize the efficacy, safety, convenience and cost-effectiveness of its product candidates.

Verus Pharmaceuticals

Verus Pharmaceuticals is developing products treating asthma

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physicians in the treatment of neurodegenerative diseases. The Company is collaborating with global ALS specialists and seeking input from patient advocacy organizations to help inform the clinical development path and better understand the needs of people affected by the disease.

Chimeric Therapies

Developer of bone marrow graft engineering to expand the use of safe and effective cellular grafts tailored to treat and cure diseases of the immune system and blood system.

United Biomedical

United Biomedical operates as a biopharmaceutical company. The Company develops immunotherapeutics and vaccines for chronic and infectious diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.